Page last updated: 2024-10-28

ifosfamide and Carcinoma, Intraductal, Noninfiltrating

ifosfamide has been researched along with Carcinoma, Intraductal, Noninfiltrating in 1 studies

Carcinoma, Intraductal, Noninfiltrating: A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franzen, D1
Pöhler, E1
Hilger, HH1

Other Studies

1 other study available for ifosfamide and Carcinoma, Intraductal, Noninfiltrating

ArticleYear
[Pneumo- and cardiotoxic side effects following combination chemotherapy with epirubicin and ifosfamide].
    Medizinische Klinik (Munich, Germany : 1983), 1990, Volume: 85 Suppl 1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Non

1990